We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
–
AUM
$408M
AUM Growth
+$45.4M
Cap. Flow
+$36.4M
Cap. Flow %
8.92%
Top 10 Hldgs %
22.24%
Holding
536
New
184
Increased
108
Reduced
56
Closed
65

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$4.5M
2
CSCO icon
Cisco
CSCO
+$4.49M
3
DD icon
DuPont de Nemours
DD
+$4.35M
4
CMCSA icon
Comcast
CMCSA
+$4.29M
5
MDT icon
Medtronic
MDT
+$4.24M

Top Sells

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$4.27M
2
IBM icon
IBM
IBM
+$4.16M
3
BSX icon
Boston Scientific
BSX
+$4.09M
4
MCD icon
McDonald's
MCD
+$4.04M
5
FISV
Fiserv Inc
FISV
+$3.54M

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 12.58%
3 Financials 10.68%
4 Communication Services 8.67%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRE
401
DELISTED
Duke Realty Corp.
DRE
$2K ﹤0.01%
+42
New +$2.38K
SIVB
402
DELISTED
SVB Financial Group
SIVB
$2K ﹤0.01%
+4
New +$2.43K
BHVN
403
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2K ﹤0.01%
+20
New +$2.49K
AZPN
404
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$2K ﹤0.01%
+12
New +$2K
AIG icon
405
American International
AIG
$42.4B
$1K ﹤0.01%
9
– –
ALGT icon
406
Allegiant Air
ALGT
$2.61B
$1K ﹤0.01%
+8
New +$1.35K
ALKS icon
407
Alkermes
ALKS
$8.11B
$1K ﹤0.01%
+53
New +$1.31K
ALT icon
408
Altimmune
ALT
$585M
$1K ﹤0.01%
125
– –
ARES icon
409
Ares Management
ARES
$31.2B
$1K ﹤0.01%
+17
New +$1.31K
BB icon
410
BlackBerry
BB
$5.15B
$1K ﹤0.01%
75
– –
BILL icon
411
BILL Holdings
BILL
$4.68B
$1K ﹤0.01%
+5
New +$1.04K
BMRN icon
412
BioMarin Pharmaceuticals
BMRN
$11.9B
$1K ﹤0.01%
+14
New +$1.17K
BPMC
413
DELISTED
Blueprint Medicines
BPMC
$1K ﹤0.01%
+17
New +$1.22K
COMP icon
414
Compass
COMP
$9.4B
$1K ﹤0.01%
70
– –
CRL icon
415
Charles River Laboratories
CRL
$12.8B
$1K ﹤0.01%
+5
New +$1.54K
CVCO icon
416
Cavco Industries
CVCO
$4.45B
$1K ﹤0.01%
6
– –
DOMO icon
417
Domo
DOMO
$179M
$1K ﹤0.01%
+28
New +$1.27K
FBIN icon
418
Fortune Brands Innovations
FBIN
$6.01B
$1K ﹤0.01%
+12
New +$923
HUBS icon
419
HubSpot
HUBS
$10.4B
$1K ﹤0.01%
+3
New +$1.45K
HURN icon
420
Huron Consulting
HURN
$2.39B
$1K ﹤0.01%
+19
New +$876
HXL icon
421
Hexcel
HXL
$7.79B
$1K ﹤0.01%
+25
New +$1.38K
INDS icon
422
Pacer Industrial Real Estate ETF
INDS
$116M
$1K ﹤0.01%
10
– –
IOVA icon
423
Iovance Biotherapeutics
IOVA
$2.77B
$1K ﹤0.01%
+57
New +$881
JAMF
424
DELISTED
Jamf
JAMF
$1K ﹤0.01%
+18
New +$611
JAZZ icon
425
Jazz Pharmaceuticals
JAZZ
$16.7B
$1K ﹤0.01%
+9
New +$1.31K
15 16
17
18 19

Similar funds

PSP
Principal Street Partners Memphis, Tennessee $613M AUM 26.72% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
1SAMC
12th Street Asset Management Company Nashville, Tennessee $611M AUM 27.12% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $611M AUM
DTL
Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return

Providence Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Providence Capital Advisors held 536 positions worth $408M, up 13% from $363M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Providence Capital Advisors deployed $36.4M of net new capital in Q1 2022, opening 184 new positions and adding to 108 existing holdings. Its largest new stake was DuPont de Nemours: 44,534 shares worth $4.09M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dow Inc, an estimated $4.27M trimmed.

  • Providence Capital Advisors's largest Q1 2022 buy was DuPont de Nemours: 44,534 shares worth $4.09M.
  • Providence Capital Advisors added most to Linde in Q1 2022, an estimated $4.5M increase.
  • Providence Capital Advisors's biggest Q1 2022 reduction was Dow Inc, cutting an estimated $4.27M.
  • Providence Capital Advisors fully exited Boston Scientific in Q1 2022, selling an estimated $4.09M.
  • Providence Capital Advisors's ten largest holdings make up 22% of its $408M portfolio in Q1 2022.
  • Providence Capital Advisors opened 184 new positions and closed 65 in Q1 2022.
  • Providence Capital Advisors's portfolio value rose 13% quarter-over-quarter to $408M.

Based on Providence Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.